KR102339610B1 - 신규의 융합된 이미다조벤조티아졸 화합물 - Google Patents

신규의 융합된 이미다조벤조티아졸 화합물 Download PDF

Info

Publication number
KR102339610B1
KR102339610B1 KR1020167029134A KR20167029134A KR102339610B1 KR 102339610 B1 KR102339610 B1 KR 102339610B1 KR 1020167029134 A KR1020167029134 A KR 1020167029134A KR 20167029134 A KR20167029134 A KR 20167029134A KR 102339610 B1 KR102339610 B1 KR 102339610B1
Authority
KR
South Korea
Prior art keywords
imidazo
butyl
tert
pyrazol
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020167029134A
Other languages
English (en)
Korean (ko)
Other versions
KR20160129089A (ko
Inventor
푼들릭 신드
산제이 스리바스타바
다빈다르 툴리
디팍 라이
프라샨트 지제이
샤일레시 데시판드
라메시찬드라 굽타
비제이 차우타이왈르
차이타냐 두트
Original Assignee
토렌트 파마슈티칼스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 토렌트 파마슈티칼스 리미티드 filed Critical 토렌트 파마슈티칼스 리미티드
Publication of KR20160129089A publication Critical patent/KR20160129089A/ko
Application granted granted Critical
Publication of KR102339610B1 publication Critical patent/KR102339610B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
KR1020167029134A 2014-03-27 2015-03-24 신규의 융합된 이미다조벤조티아졸 화합물 Expired - Fee Related KR102339610B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1089MU2014 2014-03-27
IN1089/MUM/2014 2014-03-27
PCT/IB2015/052124 WO2015145336A1 (en) 2014-03-27 2015-03-24 Novel fused imidazobenzothiazole compounds

Publications (2)

Publication Number Publication Date
KR20160129089A KR20160129089A (ko) 2016-11-08
KR102339610B1 true KR102339610B1 (ko) 2021-12-14

Family

ID=54194050

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167029134A Expired - Fee Related KR102339610B1 (ko) 2014-03-27 2015-03-24 신규의 융합된 이미다조벤조티아졸 화합물

Country Status (30)

Country Link
US (2) US9908898B2 (enExample)
EP (1) EP3122755B1 (enExample)
JP (1) JP6480949B2 (enExample)
KR (1) KR102339610B1 (enExample)
CN (1) CN106414458B (enExample)
AR (1) AR099867A1 (enExample)
AU (1) AU2015237840B2 (enExample)
CA (1) CA2943098C (enExample)
CY (1) CY1121147T1 (enExample)
DK (1) DK3122755T3 (enExample)
EA (1) EA029745B9 (enExample)
ES (1) ES2707099T3 (enExample)
HR (1) HRP20190121T1 (enExample)
HU (1) HUE042493T2 (enExample)
IL (1) IL247955B (enExample)
LT (1) LT3122755T (enExample)
MX (1) MX368985B (enExample)
MY (1) MY193041A (enExample)
PH (1) PH12016501903B1 (enExample)
PL (1) PL3122755T3 (enExample)
PT (1) PT3122755T (enExample)
RS (1) RS58324B1 (enExample)
SG (1) SG11201607793RA (enExample)
SI (1) SI3122755T1 (enExample)
SM (1) SMT201900036T1 (enExample)
TR (1) TR201900735T4 (enExample)
TW (1) TWI648282B (enExample)
UA (1) UA121469C2 (enExample)
WO (1) WO2015145336A1 (enExample)
ZA (1) ZA201606598B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX379228B (es) 2013-03-15 2025-03-10 Global Blood Therapeutics Inc Compuestos y usos de estos para la modulación de la hemoglobina.
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
TWI648282B (zh) * 2014-03-27 2019-01-21 印度商托仁特生技有限公司 新熔合咪唑苯并噻唑化合物
DE102016209204A1 (de) 2016-05-27 2017-11-30 Robert Bosch Gmbh Vorrichtung zur Regelung mindestens eines Fluidstroms in einem Fahrzeug
KR102630959B1 (ko) * 2016-10-31 2024-01-29 엘지디스플레이 주식회사 유기 화합물과 이를 이용한 발광다이오드 및 유기발광다이오드 표시장치
CN106727538A (zh) * 2017-02-20 2017-05-31 潘连香 一种治疗2型糖尿病的药物组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029922A1 (en) 1994-04-29 1995-11-09 Pharmacia & Upjohn Company Methanol derivatives for treatment of retroviral infections especially hiv infections
US20060122178A1 (en) 2001-06-26 2006-06-08 Cottam Howard B Compounds having activity as inhibitors of apoptosis
WO2007091152A1 (en) 2006-02-09 2007-08-16 Pfizer Limited Triazolopyridine compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724566D0 (en) * 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
GB8908845D0 (en) * 1989-04-19 1989-06-07 Roussel Lab Ltd Chemical compounds
AU2001294515A1 (en) 2000-08-11 2002-02-25 The Regents Of The University Of California Use of stat-6 inhibitors as therapeutic agents
BR0316506A (pt) * 2002-11-25 2005-10-04 Pharmacia Corp Midas e ácidos heteroarilsulfonilmetil hidroxâmicos e sua aplicação como inibidores da protease
GB0320244D0 (en) * 2003-05-06 2003-10-01 Aventis Pharma Inc Pyrazoles as inhibitors of tumour necrosis factor
TWI648282B (zh) * 2014-03-27 2019-01-21 印度商托仁特生技有限公司 新熔合咪唑苯并噻唑化合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029922A1 (en) 1994-04-29 1995-11-09 Pharmacia & Upjohn Company Methanol derivatives for treatment of retroviral infections especially hiv infections
US20060122178A1 (en) 2001-06-26 2006-06-08 Cottam Howard B Compounds having activity as inhibitors of apoptosis
WO2007091152A1 (en) 2006-02-09 2007-08-16 Pfizer Limited Triazolopyridine compounds

Also Published As

Publication number Publication date
AR099867A1 (es) 2016-08-24
SMT201900036T1 (it) 2019-02-28
MY193041A (en) 2022-09-23
CN106414458A (zh) 2017-02-15
PH12016501903A1 (en) 2017-01-09
MX2016012535A (es) 2017-05-04
SI3122755T1 (sl) 2019-02-28
IL247955A0 (en) 2016-11-30
US20170107233A1 (en) 2017-04-20
MX368985B (es) 2019-10-23
US10227361B2 (en) 2019-03-12
UA121469C2 (uk) 2020-06-10
EA201691920A1 (ru) 2017-01-30
PH12016501903B1 (en) 2019-04-26
TR201900735T4 (tr) 2019-02-21
ZA201606598B (en) 2017-11-29
LT3122755T (lt) 2019-02-11
KR20160129089A (ko) 2016-11-08
IL247955B (en) 2021-02-28
HUE042493T2 (hu) 2019-07-29
CN106414458B (zh) 2019-10-29
AU2015237840B2 (en) 2019-06-20
HRP20190121T1 (hr) 2019-03-08
CA2943098C (en) 2022-07-05
TWI648282B (zh) 2019-01-21
JP6480949B2 (ja) 2019-03-13
US9908898B2 (en) 2018-03-06
CY1121147T1 (el) 2020-05-29
EP3122755A1 (en) 2017-02-01
TW201613941A (en) 2016-04-16
NZ724342A (en) 2021-02-26
WO2015145336A1 (en) 2015-10-01
CA2943098A1 (en) 2015-10-01
US20180127437A1 (en) 2018-05-10
EA029745B1 (ru) 2018-05-31
ES2707099T3 (es) 2019-04-02
EP3122755B1 (en) 2018-11-07
DK3122755T3 (en) 2019-02-18
PL3122755T3 (pl) 2019-05-31
SG11201607793RA (en) 2016-10-28
RS58324B1 (sr) 2019-03-29
PT3122755T (pt) 2019-01-30
JP2017513825A (ja) 2017-06-01
EA029745B9 (ru) 2018-08-31
AU2015237840A1 (en) 2016-09-29

Similar Documents

Publication Publication Date Title
US10227361B2 (en) Fused imidazobenzothiazole compounds
JP7609790B2 (ja) イミダゾピリジニル化合物及び神経変性障害の処置のためのその使用
JP2021505684A (ja) ヒストンデアセチラーゼ６阻害剤としての１，２，４−オキサジアゾール誘導体
US20130059850A1 (en) Aza-indole derivatives useful as modulators of faah
US20190127381A1 (en) Substituted fused pyrimidinone compounds
ES2731429T3 (es) Compuestos de indanilurea inhibidores de MAP quinasa P38
WO2020153431A1 (ja) エステル化合物
TW201835041A (zh) 具β-腎上腺素促效劑及抗蕈毒活性化合物
NZ724342B2 (en) Novel fused imidazobenzothiazole compounds

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20241211

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20241211

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20241211